Yan Xu

4.2k citations
101 papers · 2.7k indexed · h-index 29
Topics
Immunotherapy and Immune Responses (24 papers)HIV Research and Treatment (22 papers)Chemokine receptors and signaling (14 papers)

In The Last Decade

Yan Xu

98 papers receiving 2.6k citations

Peers

Yan Xu
Comparison fields: 5 of 114
  • Virology 1.1k
  • Immunology 1.1k
  • Molecular Biology 762
  • Infectious Diseases 651
  • Epidemiology 578
Replace Simona Fiorentini with:
Simona Fiorentini Italy
Andrew N. Harman Australia
Thomas Harrer Germany
Vernon C. Maino United States
Kurt Vermeire Belgium
Martha A. Alexander‐Miller United States
John Hural United States
Silvia Ghezzi Italy
Miroslav Malkovský United States
Alison Simmons United Kingdom
Yan Xu relative to Simona Fiorentini Italy Simona Fiorentini's profile →
Citations per field
00.5×1.5×2.2×
Simona Fiorentini · 1×
Citations per year

Countries citing papers authored by Yan Xu

Since Specialization
Citations

This map shows the geographic impact of Yan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Xu more than expected).

Fields of papers citing papers by Yan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Xu. The network helps show where Yan Xu may publish in the future.

Co-authorship network of co-authors of Yan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Xu. A scholar is included among the top collaborators of Yan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Xu. Yan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3 1
4 0
5 1
6 22
7 4
8 1
9 19
10 21
11 4
12 22
13
Ras-ERK1/2 Signaling Promotes The Development Of Osteosarcoma By Regulating H2BK12ac Through CBP
1
14 21
15 25
16 20
17 52
18 45
19 44
20 28

About Yan Xu

Yan Xu is a scholar working on Virology, Immunology and General Engineering, having authored 101 papers that have together received 2.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (24 papers), HIV Research and Treatment (22 papers) and Chemokine receptors and signaling (14 papers). The work is most often cited by research in Virology (1.1k citations), Immunology (1.1k citations) and Infectious Diseases (651 citations). Yan Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Harriet L. Robinson, Roger J. Pomerantz, Joseph Kulkosky, Julie Sullivan, Giuseppe Nunnari, Jing An, Ziwei Huang, Ted M. Ross, Rick A. Bright and Edward Acheampong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026